Cargando…
The antitumor potential of Interleukin-27 in prostate cancer
Prostate cancer (PCa) is of increasing significance worldwide as a consequence of the population ageing. Fragile elderly patients may particularly benefit from noninvasive and well tolerable immunotherapeutic approaches. Preclinical studies have revealed that the immune-regulatory cytokine IL-27 may...
Autores principales: | Di Carlo, Emma, Sorrentino, Carlo, Zorzoli, Alessia, Di Meo, Serena, Tupone, Maria Grazia, Ognio, Emanuela, Mincione, Gabriella, Airoldi, Irma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279376/ https://www.ncbi.nlm.nih.gov/pubmed/24681516 |
Ejemplares similares
-
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression
por: Esposito, Silvia, et al.
Publicado: (2015) -
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer
por: Airoldi, Irma, et al.
Publicado: (2015) -
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis
por: Russo, Marco Vincenzo, et al.
Publicado: (2015) -
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival
por: Sorrentino, Carlo, et al.
Publicado: (2019) -
Potential clinical application of interleukin-27 as an antitumor agent
por: Yoshimoto, Takayuki, et al.
Publicado: (2015)